Health experts, scientists to discuss bird flu studies
February 10, 2012 in Diseases, Conditions, SyndromesThe World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.
The two-day discussion will relate to research on a mutation of the H5N1 virus that international scientists halted on January 20 citing fears of the devastation it could wreak were it to escape the laboratory.
According to WHO, avian influenza H5N1 is primarily transmitted between birds, and very rarely to humans.
Two separate teams of researchers, one in the Netherlands and the other in the United States, found ways late last year to engineer the H5N1 virus so that it is transmitted among mammals, something that has been rare.
The breakthrough raised alarm that the method could fall into the wrong hands and unleash a massive flu pandemic that could cost millions of lives.
A US advisory panel in December urged that key details remain unpublished.
WHO said it will hold a technical meeting on Wednesday and Thursday on the specific circumstances and results of the two studies.
"There will be 22 participants: two teams of researchers, representatives of the influenza laboratory network and representatives of the scientific newspapers Science and Nature" said WHO spokeswoman Fadela Chaib.
They will try to reach a consensus about practical actions to resolve the most urgent issues, particularly those related to access to and dissemination of the results of this research, WHO said.
(c) 2012 AFP
-
Bird flu researchers agree to 60-day halt (Update 2)
Jan 20, 2012 |
not rated yet |
0
-
US official says bird flu limits not 'censorship'
Dec 21, 2011 |
not rated yet |
0
-
WHO 'deeply concerned' by mutant bird flu
Dec 31, 2011 |
not rated yet |
0
-
Four US swans die from bird flu virus
Feb 02, 2012 |
not rated yet |
0
-
Indonesia reports second bird flu death this year
Jan 20, 2012 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
4.5 / 5 (2) |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Flesh-Eating bacteria no cause for panic, experts say
(HealthDay) -- Despite scary headlines by the score, most people don't have to fear that they'll be the next victim of the so-called flesh-eating bacteria disease, experts say.
Diseases, Conditions, Syndromes
May 25, 2012 |
not rated yet |
0
World Health Assembly endorses new plan to increase global access to vaccines
Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to ...
Diseases, Conditions, Syndromes
May 25, 2012 |
not rated yet |
1
Physicians definitively links irritable bowel syndrome and bacteria in gut
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold ...
Diseases, Conditions, Syndromes
May 25, 2012 |
not rated yet |
0
|
Study provides compelling evidence for an effective new treatment for tinnitus
According to new research, a multidisciplinary approach to treating tinnitus that combines cognitive behaviour therapy with sound-based tinnitus retraining therapy is significantly more effective than currently available ...
Diseases, Conditions, Syndromes
May 24, 2012 |
not rated yet |
0
Infections may be deadly for many dialysis patients
An infection called peritonitis commonly arises in the weeks before many dialysis patients die, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings sugges ...
Diseases, Conditions, Syndromes
May 24, 2012 |
not rated yet |
0
T cells 'hunt' parasites like animal predators seek prey, study shows
By pairing an intimate knowledge of immune-system function with a deep understanding of statistical physics, a cross-disciplinary team at the University of Pennsylvania has arrived at a surprising finding: T cells use a movement ...
Same gene that stunts infants' growth also makes them grow too big: research
UCLA geneticists have identified the mutation responsible for IMAGe* syndrome, a rare disorder that stunts infants' growth. The twist? The mutation occurs on the same gene that causes Beckwith-Wiedemann syndrome, which makes ...
Almost half of new vets seek disability
(AP) -- America's newest veterans are filing for disability benefits at a historic rate, claiming to be the most medically and mentally troubled generation of former troops the nation has ever seen.
Color-changing contact lenses to help diabetics (w/ Video)
For the millions of Americans with diabetes, the inconvenient and often painful method of testing blood sugar levels is a way of life. But research and innovative product design by scientists at The University of Akron may ...
Missouri opts for untested drug for executions
(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.